title: Anaphylaxis to gadolinium radiocontrast: a case report and review of the literature.
abstract: Gadolinium was first introduced in 1988 for use in magnetic resonance imaging. The safety of gadolinium chelates is well established with lower frequency of adverse reactions than non-ionic iodinated contrast media; however, serious adverse reactions can occur. We report a rare case of anaphylaxis after intravenous administration of gadopentetate dimeglumine (Magnevist), used for magnetic resonance imaging.
authors.affiliation: Internal Medcine-Pediatrics, Louisiana State University Health Sciences Center, New Orleans, USA.
authors.forename: Meagan
authors.initials: M
authors.lastname: Shepherd
authors.forename: Suman
authors.initials: S
authors.lastname: Lata
authors.forename: Sandhya
authors.initials: S
authors.lastname: Mani
authors.forename: Annette
authors.initials: A
authors.lastname: Fiorillo
authors.forename: Prem
authors.initials: P
authors.lastname: Kumar
mesh_terms: D000707:Anaphylaxis / Q000097:blood / Q000209:etiology*; D003287:Contrast Media / Q000009:adverse effects*; D005260:Female; D019786:Gadolinium DTPA / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D053802:Tryptases / Q000097:blood
chemical_list: D003287:Contrast Media; D053802:Tryptases; D019786:Gadolinium DTPA